The protocol spoke bladder. Patients were thinking about memory.

After nine months of underperformance, patient discussions showed that many older people were more worried about their memory than their bladder symptoms. Older bladder treatments are linked to memory problems, and the study drug worked differently. We rebuilt the conversation around what patients cared about, using what the protocol already offered.